Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2020; 66(2-3): 44-50


I.N. Mikheytseva1, V.R. Yurevich2

  1. Filatov Institute of Eye Diseases and Tissue Therapy of NAMS of Ukraine, Odesa, Ukraine
  2. Danylo Halytsky Lviv National Medical University, Ukraine


The study of interconnection of redox processes and carbonyl metabolism as mechanisms of cell damage and the formation of oxidative and carbonyl stress as pathogenetic factors of many pathological conditions in the body is one of the topical problem of modern biomedical sciences. Primary glaucoma and diabetes mellitus are just such diseases. A problem that needs to be solved is also the development of effective and safe ways of correcting these disoders. The study examined the possibility of correcting with benfotiamine (BFT) the metabolic state of carbonyls in the tissues of the eye filtering apparatus of the animals, which were modeled glaucoma by forming high intraocular pressure against streptozotocin diabetes. BFT was administered per os (50 mg per day, 17 mg/kg body weight) for 2 months. It effectively affected the level of toxic carbonyl metabolites: it reduced the accumulation of methylglyoxal, glyoxal, acetoacetate and the content of carbonyl groups of proteins, that indicates a decrease in dicarbonyl stress in the drainage zone tissues of the rabbit’s eyes. Such metabolic activity of BFT in the eye tissues can be very useful in the development of pathogenetically directed therapy for patients with glaucoma and diabetes.

Keywords: glaucoma; diabetes; carbonyl stress; eye tissue; benfotiamine.


  1. Gülgün Tezel. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res. 2006; 25(5): 490-513. CrossRef PubMed PubMedCentral
  3. Paloma B Liton, Pedro Gonzalez. Stress response of the trabecular meshwork J Glaucoma. 2008;17(5):378-85. CrossRef PubMed PubMedCentral
  5. Sacca SG, Izzotti A, Rossi P, Traverso C. Glaucomatous outflow pathway and oxidative stress. Exp Eye Res. 2007; 84:389-99. CrossRef PubMed
  7. Astahov YuS, Krylova IS, Shadrichev FE. Is diabetes a risk factor for primary open-angle glaucoma. Klin Oftalmol. 2006;7(3):91-4. [Russian].
  9. Vorobyeva IV, Sherbakova EV. Glaucoma and diabetic retinopathy in patients with type 2 diabetes. Oftalmologiya. 2014;11(3):4-12. [Russian].
  11. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352: 837-53. CrossRef  
  12. Toeller M, Buyken AE, Heitkamp G, et al. Prevalence of chronic complications, metabolic control and nutritional intake in type 1 diabetes: comparison between different European regions. EURUDIAB Complications Study group. Horm Metab Res. 1999;31:680-5. CrossRef PubMed
  14. Korkushko OV, Shatilo VB, Chizhova VP, et al. The body's response to an acute hypoxic test in healthy humans and individuals with prediabetic disorders of carbohydrate metabolism. Fiziol Zh. 2016;62(1):34-42. CrossRef PubMed
  16. Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol. 2008;153(1):6-20. CrossRef PubMed PubMedCentral
  18. Caballero M, Liton PB, Challa P, Epstein DL, Gonzalez P. Effects of donor age on proteasome activity and senescence in trabecular meshwork cells. Biochem Biophys Res Commun. 2004;323(3):1048-54. CrossRef PubMed
  20. Seung Hee Lee, Sin Hoo Kim, Jae Woo Kim. Effect of methylglyoxal on the oxidative stress in trabecular meshwork cells. J Korean Ophthalmol Soc. 2009;50(10):1569-75. CrossRef  
  21. Yurevich VR. The effect of ophthalmic hypertension on the level of glycation products in tissues of the anterior chamber angle of the eye of animals with streptozotocin diabetes. Oftalmol Zh. 2016;1:43-47. [Russian]. CrossRef  
  22. Yurevich VR, Mikheitseva IN. Dicarbonyl stress in eye tissues of rabbits with ocular hypertension in experimental diabetes. Ukr Zh Med Biol Sportu. 2019;2(18):100-6. [Russian]. CrossRef  
  23. Hammes H, Du X, Edelstein D et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents expirimental diabetic retinopathy. Nature Med. 2003; 9:1-6. CrossRef PubMed
  25. Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ. Prevention of Incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes. 2003;52:2110-19. CrossRef PubMed
  27. Stracke H, Gaus W, Achenbach U, et al. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical trial. Exp Cli . Endocrin Diabetes. 2008;116:1-6. CrossRef PubMed
  29. Ceylan-Isik AF, Wu S, Li Q, et al. High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus. J Appl Phisiol. 2006;100:150-6. CrossRef PubMed
  31. Stirban A, Negrean M, Stratmann B, et al. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care. 2006;29( 9):2064-71. CrossRef PubMed
  33. Stracke H, Hammes H P, Werkmann K, et al. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp Clin Diabetes. 2001;109:330-6. CrossRef PubMed
  35. Masood Saleem Mir, Mohammad Maqbool Darzi, Omer Khalil Baba, et al. Streptozotocin induced acute clinical effects in rabbits. Iran J Pathol. 2015;10(3):206-13. 21. Zhu MD, Cai FY. Development of experimental chronic intraocular hypertension in the rabbit. Austral and New Zeland J Ophthalmol. 1992;20:225-34. CrossRef PubMed
  37. Bergmeyer HU. Metoden der enzimatischen analyse . herausgegeben von H.U. Bergmeyer. Berlin, 1970;1454- 56;1776-79.
  39. Dechary JM, Kun E, Pitot HC. Spectrophotometric determination of ethanedial. Anal Chem. 1954;26:449-52. CrossRef  
  40. Davanand CD, Vegi PK. Protein carbonyl content as a stable oxidative stress marker in type II diabetes. Int J Biol Med Res. 2012;3:2362-5.
  42. Thornalley P J, Jahan I, Ng R. Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. J Biochem. 2001;129: 543-9. CrossRef PubMed
  44. Kozlov SG, Gabbasov ZA, Byazrova SV. Excessive formation of glycation end products as a possible reason for the increased risk of restenosis after stenting of coronary arteries in patients with diabetes mellitus. Ateroskleroz i dislipidemii. 2015;3:5-13. [Russian].
  46. Wautier J-L and Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res. 2004;95:233-8. CrossRef PubMed
  48. Aso Y, Inukai T, Tayama K. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes. Acta Diabetol. 2000;37(2):87-92. CrossRef PubMed
  50. Wu S, Ren J. Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha. Neurosci Lett. 2006;394(2):158-62. CrossRef PubMed

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.